The article provides an overview of cancer survivorship statistics and treatment patterns in the United States as of January 1, 2016, with projections to January 1, 2026. It highlights the increasing number of cancer survivors due to advancements in early detection and treatment, as well as an aging and growing population. The American Cancer Society and the National Cancer Institute collaborate to estimate the number of current and future cancer survivors using data from cancer registries. The most prevalent cancers among males are prostate, colon and rectum, and melanoma, while among females, they are breast, uterine corpus, and colon and rectum. Over half of the survivors were diagnosed within the past 10 years, and nearly half are aged 70 or older. The article also discusses treatment patterns, survival rates, and long-term health effects for specific cancers, including breast, colorectal, leukemia, lymphoma, lung, melanoma, prostate, testis, and thyroid cancers. It emphasizes the need for proactive assessment and management of unique medical and psychosocial needs by primary care providers, as well as the development of evidence-based resources to optimize care for cancer survivors.The article provides an overview of cancer survivorship statistics and treatment patterns in the United States as of January 1, 2016, with projections to January 1, 2026. It highlights the increasing number of cancer survivors due to advancements in early detection and treatment, as well as an aging and growing population. The American Cancer Society and the National Cancer Institute collaborate to estimate the number of current and future cancer survivors using data from cancer registries. The most prevalent cancers among males are prostate, colon and rectum, and melanoma, while among females, they are breast, uterine corpus, and colon and rectum. Over half of the survivors were diagnosed within the past 10 years, and nearly half are aged 70 or older. The article also discusses treatment patterns, survival rates, and long-term health effects for specific cancers, including breast, colorectal, leukemia, lymphoma, lung, melanoma, prostate, testis, and thyroid cancers. It emphasizes the need for proactive assessment and management of unique medical and psychosocial needs by primary care providers, as well as the development of evidence-based resources to optimize care for cancer survivors.